Skip links and keyboard navigation

Patient-class prescribers

Under the Public Health (Medicinal Cannabis) Act 2016 (PHMCA), a patient-class prescriber is defined as a specialist health practitioner, or a registrar (under the supervision of a specialist), in the specialities of:

  • palliative medicine
  • general paediatricians
  • gynaecological oncologists
  • haematologist physicians
  • medical oncologists
  • neurologists
  • paediatric medical oncologists
  • paediatric neurologists
  • paediatric palliative medicine physicians
  • radiation oncologists.

To be a patient–class prescriber you must:

  • be a specialist medical practitioner, as specified in the PHMCA, and be listed with Queensland Health as a patient-class prescriber
  • be registered (without undertakings on your registration) with the Australian Health Practitioners Regulation Agency
  • have an established treating relationship with the patient

OR

  • be in direct communication with another medical practitioner who has an established long-term treating relationship with the patient and both are in well-documented agreement with the application for medicinal cannabis approval for therapeutic purposes.

Guidance and regulations

Forms and templates

Requirements

The patient-class prescriber must:

  • notify Queensland Health prior to commencing treating patients with the specified medicinal cannabis product
  • comply with the requirements of the PHMCA and regulation
  • obtain informed written consent for the treatment of the patient with the medicinal cannabis product (s) and retain a copy on the patient record
  • obtain a written driving acknowledgement from the patient advising the patient that they are not able to drive if they are taking THC based medicinal cannabis products and retain a copy on the patient record
  • ensure the medicinal cannabis product is stored in accordance with the manufacturers specifications and meets  the requirements of the security standard  if they are dispensing the medication from their practice
  • prepare a medicinal cannabis management plan  (if the prescriber is supplying/dispensing from their practice) under the medicinal cannabis approval
  • notify Queensland Health when a medicinal cannabis management plan is made
  • notify Queensland Health when a patient has commenced treatment with a specified medicinal cannabis product
  • provide a treatment report  to the chief executive at 3 monthly intervals
  • comply with any conditions imposed on a TGA approval relating to the medicinal cannabis product (s) being used
Last updated: 1 March 2017